Organigram Holdings Inc. (TSE:OGI - Get Free Report)'s share price traded down 16% on Tuesday . The stock traded as low as C$2.07 and last traded at C$2.10. 233,905 shares traded hands during trading, an increase of 8% from the average session volume of 217,406 shares. The stock had previously closed at C$2.50.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the company. Canaccord Genuity Group lowered their target price on Organigram from C$3.60 to C$3.15 and set a "speculative buy" rating on the stock in a report on Monday, December 9th. ATB Capital lowered their target price on Organigram from C$5.25 to C$3.50 in a report on Tuesday, December 17th.
Get Our Latest Analysis on Organigram
Organigram Stock Down 5.7 %
The stock has a market capitalization of C$223.61 million, a price-to-earnings ratio of -3.83, a PEG ratio of 0.42 and a beta of 1.13. The business has a fifty day moving average of C$2.24 and a 200 day moving average of C$2.31. The company has a debt-to-equity ratio of 3.07, a current ratio of 3.36 and a quick ratio of 2.62.
About Organigram
(
Get Free Report)
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Read More
Before you consider Organigram, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.
While Organigram currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.